219 related articles for article (PubMed ID: 6607744)
21. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
Hoem NO; Briseid K
Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
[TBL] [Abstract][Full Text] [Related]
22. Activation of human Hageman factor (factor XII) in the presence of zinc and phosphate ions.
Shibayama Y; Brunnee T; Kaplan AP; Reddigari S
Braz J Med Biol Res; 1994 Aug; 27(8):1817-28. PubMed ID: 7749371
[TBL] [Abstract][Full Text] [Related]
23. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
Bouma BN; Miles LA; Beretta G; Griffin JH
Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
[TBL] [Abstract][Full Text] [Related]
24. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
Tankersley DL; Alving BM; Finlayson JS
Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
[TBL] [Abstract][Full Text] [Related]
25. Alpha 2-macroglobulin-kallikrein potentiates contact system activity: possible effect in asthma.
Freyria AM; Lasser EC; Lyon SG; Simon RA
Int Arch Allergy Appl Immunol; 1987; 83(4):341-7. PubMed ID: 2440813
[TBL] [Abstract][Full Text] [Related]
26. Initiation of contact activation by sulfatides.
Tans G; Griffin JH
Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
[TBL] [Abstract][Full Text] [Related]
27. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
28. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
29. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
Johansen HT; Briseid K
Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
[TBL] [Abstract][Full Text] [Related]
30. A monoclonal anti-human plasma prekallikrein antibody that inhibits activation of prekallikrein by factor XIIa on a surface.
Veloso D; Silver LD; Hahn S; Colman RW
Blood; 1987 Oct; 70(4):1053-62. PubMed ID: 2443201
[TBL] [Abstract][Full Text] [Related]
31. Surface-dependent activation of human factor XII (Hageman factor) by kallikrein and its light chain.
Rosing J; Tans G; Griffin JH
Eur J Biochem; 1985 Sep; 151(3):531-8. PubMed ID: 3875484
[TBL] [Abstract][Full Text] [Related]
32. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
Shimada T; Kato H; Iwanaga S
J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
[TBL] [Abstract][Full Text] [Related]
33. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
[TBL] [Abstract][Full Text] [Related]
34. Influence of Zn2+ on the kinetic events that contribute to the 500-kDa dextran-sulfate-dependent activation of factor XII (Hageman factor).
Loiseau C; Randriamahazaka HN; Nigretto JM
Eur J Biochem; 1997 May; 246(1):204-10. PubMed ID: 9210485
[TBL] [Abstract][Full Text] [Related]
35. Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies.
Samuel M; Pixley RA; Villanueva MA; Colman RW; Villanueva GB
J Biol Chem; 1992 Sep; 267(27):19691-7. PubMed ID: 1527088
[TBL] [Abstract][Full Text] [Related]
36. Properties of sulfatides in factor-XII-dependent contact activation.
Tans G; Griffin JH
Blood; 1982 Jan; 59(1):69-75. PubMed ID: 6914902
[TBL] [Abstract][Full Text] [Related]
37. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
[TBL] [Abstract][Full Text] [Related]
38. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
[TBL] [Abstract][Full Text] [Related]
39. Activation of the contact system of coagulation by a monoclonal antibody directed against a neodeterminant in the heavy chain region of human coagulation factor XII (Hageman factor).
Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Meijers JC; Bouma BN; Hack CE
J Biol Chem; 1989 Aug; 264(22):12941-9. PubMed ID: 2473984
[TBL] [Abstract][Full Text] [Related]
40. Dextran sulphate inhibits phospholipid and sulphatide mediated autoactivation of factor XII.
Schousboe I; Rasmussen MS; Lintner R
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):503-9. PubMed ID: 7841305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
